Advaxis is currently conducting a series of clinical trials for the treatment of various cancers. In addition, the company has a pre-clinical program with 15 immunotherapies in development for cancers and infectious diseases.
| Clinical Pipeline | ||||
|---|---|---|---|---|
| CONSTRUCT | INDICATION | PRE-CLINICAL | PHASE 1 | PHASE 2 |
| ADXS-HPV | CIN (Cervical Dysplasia), US |  |
|
 |
| ADXS-HPV | Cervical Cancer, US, NCI/GOG | |
|
|
| ADXS-HPV | Cervical Cancer, India | |
|
|
| ADXS-HPV | Head & Neck Cancer, UK, CRUK | |
|
|
| ADXS-PSA | Prostate Cancer |  |
||
| ADXS-HER2 | Breast and other cancers | |
||
| ADXS-HER2 | Canine Osteosarcoma, US, UPenn | |
|
|